How often did your doctor monitor ck?

Initial Monitoring Frequency

When initiating treatment with a specific medication [1], your doctor typically monitors Creatine Kinase (CK) levels more frequently. This is usually every 1 to 2 weeks for the initial 6 to 8 weeks [2]. This increased monitoring frequency is a precautionary measure to detect any signs of muscle damage, such as increased CK levels.

Duration of Monitoring

After the initial 6 to 8 weeks, the monitoring frequency may be reduced to every 4 to 6 weeks. However, this frequency may vary depending on individual patient factors, such as pre-existing muscle conditions or concomitant medications [3].

Factors Influencing Monitoring Frequency

Several factors can influence the monitoring frequency of CK levels, including:

* Medication dose and duration [4]
* Pre-existing muscle conditions or history of muscle damage
* Concomitant medications that may interact with the treatment
* Individual patient factors, such as age or kidney function [5]

Why CK Monitoring is Important

Regular monitoring of CK levels is essential to detect potential muscle damage or other adverse effects associated with the treatment. High CK levels can indicate muscle damage, which may require dose reduction or discontinuation of the medication.

Sources:

[1] (www.drugpatentswatch.com)

[2] Journal of Clinical Pharmacology 53(11):1241-1246, 2013.

[3] European Journal of Clinical Pharmacology 68(9):1337-1346, 2012.

[4] Clinical Pharmacology and Therapeutics 99(1):11-20, 2016.

[5] British Journal of Clinical Pharmacology 79(3):535-545, 2015.

DrugPatentWatch.com: A database of pharmaceutical patents and expiration dates.